CoChat
Sign Up
Cited by 106

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Immunohistochemical expression of folate receptor α in colorectal carcinoma: patterns and biological significance

Shia, Jinru, Klimstra, David S., Nitzkorski, James R., Low, Philip S., Gonen, Mithat, Landmann, Ron, Weiser, Martin R., Franklin, Wilbur A., Prendergast, Franklyn G., Murphy, Linda, Tang, Laura H., Temple, Larissa, Guillem, Jose G., Wong, W. Douglas, Paty, Philip B.·2008·Human Pathology
DOI 10.1016/j.humpath.2007.09.013
Open this paper in CoChat — free account

Abstract

Folate receptor alpha (FRalpha) has emerged as a potential cancer therapy target with several folate-linked therapeutic agents currently undergoing clinical trials. In addition, FRalpha expression in tumors may offer prognostic significance. Most studies on FRalpha expression used reverse transcriptase polymerase chain reaction or cytofluorimetric assays. The applicability of such methods to paraffin-embedded tissues is limited. The aims of this study were to assess the feasibility of immunohistochemistry in detecting FRalpha expression and to assess the patterns and clinical significance of FRalpha expression in colorectal tissues. We used tissue microarrays containing 152 normal colorectal mucosa samples, 42 adenomas, 177 primary, and 52 metastatic colorectal carcinomas. Our results showed that staining for FRalpha on colorectal tissues was simple and easy to read. FRalpha positivity was more frequent in carcinomas (33% in primaries and 44% in metastases) than in normal mucosa or adenoma (7% in both) (P < .001). Positive staining in primary carcinomas correlated with younger age (n = 130) (P = .008), presence of distant metastasis (n = 130) (P = .043), and non-high-frequency microsatellite instability status (as detected by the standard polymerase chain reaction method using the 5 National Cancer Institute-recommended markers) (n = 77) (P = .006). Positive staining in primary carcinomas also correlated with a worse 5-year disease-specific survival (P = .04) on univariate bu…

Overview

Integrity signals

Registry

Crossref · 10.1016/j.humpath.2007.09.013

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 1 references

Research works printed but not linked: 38

  1. Choi, 2000, Folate and carcinogenesis: an integrated scheme, J Nutr, 130, 129, 10.1093/jn/130.2.129 · DOI
  2. Antony, 1996, Folate receptors, Annu Rev Nutr, 16, 501, 10.1146/annurev.nu.16.070196.002441 · DOI
  3. Rijnboutt, 1996, Endocytosis of GPI-linked membrane folate receptor-alpha, J Cell Biol, 132, 35, 10.1083/jcb.132.1.35 · DOI
  4. Low, 2004, Folate receptor–targeted drugs for cancer and inflammatory diseases, Adv Drug Deliv Rev, 56, 1055, 10.1016/j.addr.2004.02.003 · DOI
  5. Lu, 2004, Folate receptor–targeted immunotherapy of cancer: mechanism and therapeutic potential, Adv Drug Deliv Rev, 56, 1161, 10.1016/j.addr.2004.01.009 · DOI
  6. Toffoli, 1997, Overexpression of folate binding protein in ovarian cancers, Int J Cancer, 74, 193, 10.1002/(SICI)1097-0215(19970422)74:2<193::AID-IJC10>3.0.CO;2-F · DOI
  7. Hartmann, 2007, Folate receptor overexpression is associated with poor outcome in breast cancer, Int J Cancer, 121, 938, 10.1002/ijc.22811 · DOI
  8. Parker, 2005, Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay, Anal Biochem, 338, 284, 10.1016/j.ab.2004.12.026 · DOI
  9. Leamon, 2004, Folate-targeted chemotherapy, Adv Drug Deliv Rev, 56, 1127, 10.1016/j.addr.2004.01.008 · DOI
  10. Leamon, 2006, Synthesis and biological evaluation of EC140: a novel folate-targeted vinca alkaloid conjugate, Bioconjug Chem, 17, 1226, 10.1021/bc060145g · DOI
  11. Hattori, 2005, Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase, Cancer Gene Ther, 12, 796, 10.1038/sj.cgt.7700844 · DOI
  12. Henne, 2006, Synthesis and activity of a folate peptide camptothecin prodrug, Bioorg Med Chem Lett, 16, 5350, 10.1016/j.bmcl.2006.07.076 · DOI
  13. Siegel, 2003, Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results, J Nucl Med, 44, 700
  14. Reddy, 2004, Preclinical evaluation of (99m)Tc-EC20 for imaging folate receptor-positive tumors, J Nucl Med, 45, 857
  15. Toffoli, 1998, Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer, Int J Cancer, 79, 121, 10.1002/(SICI)1097-0215(19980417)79:2<121::AID-IJC4>3.0.CO;2-V · DOI
  16. Chang, 2007, Role of MTHFR polymorphisms and folate levels in different phenotypes of sporadic colorectal cancers, Int J Colorectal Dis, 22, 483, 10.1007/s00384-006-0190-x · DOI
  17. Choi, 2002, Folate status: effects on pathways of colorectal carcinogenesis, J Nutr, 132, 2413S, 10.1093/jn/132.8.2413S · DOI
  18. Kawakami, 2006, DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer, Br J Cancer, 94, 593, 10.1038/sj.bjc.6602940 · DOI
  19. Weitman, 1992, Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues, Cancer Res, 52, 3396
  20. Evans, 2003, Differential expression of folate receptor in pituitary adenomas, Cancer Res, 63, 4218
  21. Franklin, 1994, New anti-lung-cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma, Int J Cancer Suppl, 8, 89, 10.1002/ijc.2910570719 · DOI
  22. Garin-Chesa, 1993, Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein, Am J Pathol, 142, 557
  23. Kononen, 1998, Tissue microarrays for high-throughput molecular profiling of tumor specimens, Nat Med, 4, 844, 10.1038/nm0798-844 · DOI
  24. Hoos, 2001, Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors, Am J Pathol, 158, 1245, 10.1016/S0002-9440(10)64075-8 · DOI
  25. Nash, 2003, Automated, multiplex assay for high-frequency microsatellite instability in colorectal cancer, J Clin Oncol, 21, 3105, 10.1200/JCO.2003.11.133 · DOI
  26. Shia, 2003, Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer, Am J Surg Pathol, 27, 1407, 10.1097/00000478-200311000-00002 · DOI
  27. Boland, 1998, A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer, Cancer Res, 58, 5248
  28. Gonen, 2001, Statistical issues in analysis of diagnostic imaging experiments with multiple observations per patient, Radiology, 221, 763, 10.1148/radiol.2212010280 · DOI
  29. Reddy, 2006, Folate receptor specific anti-tumor activity of folate-mitomycin conjugates, Cancer Chemother Pharmacol, 58, 229, 10.1007/s00280-005-0151-z · DOI
  30. Cravo, 1992, Folate deficiency enhances the development of colonic neoplasia in dimethylhydrazine-treated rats, Cancer Res, 52, 5002
  31. Eaton, 2005, 5,10-Methylenetetrahydrofolate reductase 677 and 1298 polymorphisms, folate intake, and microsatellite instability in colon cancer, Cancer Epidemiol Biomarkers Prev, 14, 2023, 10.1158/1055-9965.EPI-05-0131 · DOI
  32. Kim, 2004, Folate, colorectal carcinogenesis, and DNA methylation: lessons from animal studies, Environ Mol Mutagen, 44, 10, 10.1002/em.20025 · DOI
  33. de Vos tot Nederveen Cappel, 2004, Survival after adjuvant 5-FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer, Int J Cancer, 109, 468, 10.1002/ijc.11712 · DOI
  34. Ahuja, 1998, Aging and DNA methylation in colorectal mucosa and cancer, Cancer Res, 58, 5489
  35. Nakagawa, 2001, Age-related hypermethylation of the 5′ region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development, Cancer Res, 61, 6991
  36. Yuasa, 2002, DNA methylation in cancer and ageing, Mech Ageing Dev, 123, 1649, 10.1016/S0047-6374(02)00100-8 · DOI
  37. Toyota, 1999, CpG island methylator phenotype in colorectal cancer, Proc Natl Acad Sci U S A, 96, 8681, 10.1073/pnas.96.15.8681 · DOI
  38. Feinberg, 2004, The epigenetics of cancer etiology, Semin Cancer Biol, 14, 427, 10.1016/j.semcancer.2004.06.005 · DOI

Cited by

Sorted by citations

See all 106

Metadata

Authors
Shia, J., Klimstra, D. S., Nitzkorski, J. R., Low, P. S., Gonen, M., Landmann, R., Weiser, M. R., Franklin, W. A., Prendergast, F. G., Murphy, L., Tang, L. H., Temple, L., Guillem, J. G., Wong, W. D., & Paty, P. B.
Venue
Human Pathology
Publisher
Elsevier BV
Published
2008-04
Volume
39
Issue
4
Pages
498-505
ISSN
0046-8177
DOI
10.1016/j.humpath.2007.09.013
Cited by
106
References
1
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immunohistochemical expression of folate receptor α in colorectal carcinoma: patterns and biological significance. https://app.cochat.ai/papers/10.1016/j.humpath.2007.09.013
The paper
Shia, J., Klimstra, D. S., Nitzkorski, J. R., Low, P. S., Gonen, M., Landmann, R., Weiser, M. R., Franklin, W. A., Prendergast, F. G., Murphy, L., Tang, L. H., Temple, L., Guillem, J. G., Wong, W. D., & Paty, P. B. (2008). Immunohistochemical expression of folate receptor α in colorectal carcinoma: patterns and biological significance. Human Pathology. https://doi.org/10.1016/j.humpath.2007.09.013